These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 6848176)

  • 1. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
    Gilbert LC; Gordon SG
    Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
    Yu HR; Schultz RM
    Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of malignant melanoma variant cell lines for ovary colonization.
    Brunson KW; Nicolson GL
    J Supramol Struct; 1979; 11(4):517-28. PubMed ID: 544929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
    Herd ZL
    Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
    Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
    Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
    Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion of metastasis related gangliosides by mouse B16-melanoma in circulation in vivo and in culture media in vitro.
    Saha S; Mohanty KC
    Indian J Exp Biol; 2004 Oct; 42(10):976-80. PubMed ID: 15511000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
    Kure S; Yoshie O; Aso H
    Jpn J Cancer Res; 1987 Nov; 78(11):1238-45. PubMed ID: 2961717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic variants of the B16 melanoma: metastasis is related to environmental conditions. Phenotypic changes in vitro and metastatic colonization potential in nude mice.
    Aubert C
    Melanoma Res; 1995 Jun; 5(3):139-46. PubMed ID: 7640514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.
    Nicolson GL; Dulski K; Basson C; Welch DR
    Invasion Metastasis; 1985; 5(3):144-58. PubMed ID: 3997411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.
    Hao S; Ye Z; Li F; Meng Q; Qureshi M; Yang J; Xiang J
    Exp Oncol; 2006 Jun; 28(2):126-31. PubMed ID: 16837903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.
    Esumi N; Fan D; Fidler IJ
    Cancer Res; 1991 Sep; 51(17):4549-56. PubMed ID: 1873799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
    Parratto NP; Odebralski JM; Kimura AK
    Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.